These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. Park CH; Kim EH; Roh YH; Kim HY; Lee SK PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217 [TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies. Srinutta T; Chewcharat A; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P Medicine (Baltimore); 2019 Nov; 98(44):e17788. PubMed ID: 31689852 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862 [TBL] [Abstract][Full Text] [Related]
5. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851 [TBL] [Abstract][Full Text] [Related]
6. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis. Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158 [TBL] [Abstract][Full Text] [Related]
7. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis. Liao S; Gan L; Mei Z Medicine (Baltimore); 2019 Mar; 98(13):e15011. PubMed ID: 30921222 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis. Boonpheng B; Thongprayoon C; Bathini T; Sharma K; Mao MA; Cheungpasitporn W World J Transplant; 2019 Jun; 9(2):35-47. PubMed ID: 31363460 [TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Luk CP; Parsons R; Lee YP; Hughes JD Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281 [TBL] [Abstract][Full Text] [Related]
10. The association of proton pump inhibitors and hypomagnesemia in the community setting. Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616 [TBL] [Abstract][Full Text] [Related]
11. Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis. Cheungpasitporn W; Thongprayoon C; Harindhanavudhi T; Edmonds PJ; Erickson SB Endocr Res; 2016 May; 41(2):142-7. PubMed ID: 26934195 [TBL] [Abstract][Full Text] [Related]
12. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review. Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094 [TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia and proton-pump inhibitors. Famularo G; Gasbarrone L; Minisola G Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients. Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349 [TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use. Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412 [TBL] [Abstract][Full Text] [Related]
16. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis. Padhi BK; Khatib MN; Zahiruddin QS; Rustagi S; Sharma RK; Sah R; Satapathy P; Rao AP BMC Cardiovasc Disord; 2024 Jul; 24(1):372. PubMed ID: 39020285 [TBL] [Abstract][Full Text] [Related]
17. Uses of proton pump inhibitors and hypomagnesemia. Gau JT; Yang YX; Chen R; Kao TC Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212 [TBL] [Abstract][Full Text] [Related]
18. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study. Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549 [TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200 [TBL] [Abstract][Full Text] [Related]
20. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV. Sutton SS; Magagnoli J; Cummings T; Hardin JW J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]